These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 4201265

  • 1. Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule.
    Ridgway EC, Weintraub BD, Cevallos JL, Rack MC, Maloof F.
    J Clin Invest; 1973 Nov; 52(11):2783-92. PubMed ID: 4201265
    [Abstract] [Full Text] [Related]

  • 2. [The hypothalamic-Pituitary thyroid axis: studies on the regulatory role of thyrotropin releasing hormone (TRH) (author's transl)].
    Hirooka Y.
    Nihon Naibunpi Gakkai Zasshi; 1976 Sep 20; 52(9):908-25. PubMed ID: 828584
    [Abstract] [Full Text] [Related]

  • 3. The TSH response to thyrotropin-releasing hormone (TRH) in young adult men: intra-individual variation and relation to basal serum TSH and thyroid hormones.
    Sawin CT, Hershman JM.
    J Clin Endocrinol Metab; 1976 May 20; 42(5):809-16. PubMed ID: 818102
    [Abstract] [Full Text] [Related]

  • 4. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ, Utiger RD.
    J Clin Invest; 1973 Sep 20; 52(9):2305-12. PubMed ID: 4199417
    [Abstract] [Full Text] [Related]

  • 5. Variable thyrotropin response to thyrotropin-releasing hormone after small decreases in plasma free thyroid hormone concentrations in patients with nonthyroidal diseases.
    Maturlo SJ, Rosenbaum RL, Pan C, Surks MI.
    J Clin Invest; 1980 Sep 20; 66(3):451-6. PubMed ID: 6772675
    [Abstract] [Full Text] [Related]

  • 6. Partial target organ resistance to thyroid hormone.
    Bode HH, Danon M, Weintraub BD, Maloof F, Crawford JD.
    J Clin Invest; 1973 Apr 20; 52(4):776-82. PubMed ID: 4632689
    [Abstract] [Full Text] [Related]

  • 7. Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS).
    Chang SC, Thibodeaux JR, Eastvold ML, Ehresman DJ, Bjork JA, Froehlich JW, Lau C, Singh RJ, Wallace KB, Butenhoff JL.
    Toxicology; 2008 Jan 20; 243(3):330-9. PubMed ID: 18063289
    [Abstract] [Full Text] [Related]

  • 8. Pituitary unresponsiveness to thyrotropin-releasing hormone in thyrotoxic patients during chronic anti-thyroid drug therapy and in rats previously treated with excess thyroid hormone.
    Harada A, Kojima A, Tsukui T, Onaya T, Yamada T, Ikejiri K, Yukimura Y.
    J Clin Endocrinol Metab; 1975 Jun 20; 40(6):942-8. PubMed ID: 805794
    [Abstract] [Full Text] [Related]

  • 9. Augmentation of thyrotropin responses to thyrotropin-releasing hormone following small decreases in serum thyroid hormone concentrations.
    Saberi M, Utiger RD.
    J Clin Endocrinol Metab; 1975 Mar 20; 40(3):435-41. PubMed ID: 803974
    [Abstract] [Full Text] [Related]

  • 10. Hyperresponse to thyrotropin-releasing hormone accompanying small decreases in serum thyroid hormone concentrations.
    Vagenakis AG, Rapoport B, Azizi F, Portnay GI, Braverman LE, Ingbar SH.
    J Clin Invest; 1974 Oct 20; 54(4):913-8. PubMed ID: 4214837
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones.
    Snyder PJ, Utiger RD.
    J Clin Invest; 1972 Aug 20; 51(8):2077-84. PubMed ID: 4626582
    [Abstract] [Full Text] [Related]

  • 12. Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy.
    Krugman LG, Hershman JM, Chopra IJ, Levine GA, Pekary E, Geffner DL, Chua Teco GN.
    J Clin Endocrinol Metab; 1975 Jul 20; 41(1):70-80. PubMed ID: 807596
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
    Bartalena L, Martino E, Falcone M, Buratti L, Grasso L, Mammoli C, Pacchiarotti A, Aghini-Lombardi F, Balzano S, Pinchera A.
    J Clin Endocrinol Metab; 1987 Dec 20; 65(6):1265-71. PubMed ID: 3680483
    [Abstract] [Full Text] [Related]

  • 14. Modulation of pituitary responsiveness to thyrotropin-releasing hormone by triiodothyronine.
    Shenkman L, Mitsuma T, Hollander CS.
    J Clin Invest; 1973 Jan 20; 52(1):205-9. PubMed ID: 4629908
    [Abstract] [Full Text] [Related]

  • 15. The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin.
    Re RN, Kourides IA, Ridgway EC, Weintraub BD, Maloof F.
    J Clin Endocrinol Metab; 1976 Aug 20; 43(2):338-46. PubMed ID: 820709
    [Abstract] [Full Text] [Related]

  • 16. Response to thyrotropin releasing hormone: an objective criterion for the adequacy of thyrotropin suppression therapy.
    Hoffman DP, Surks MI, Oppenheimer JH, Weitzman ED.
    J Clin Endocrinol Metab; 1977 May 20; 44(5):892-901. PubMed ID: 404309
    [Abstract] [Full Text] [Related]

  • 17. Pituitary-thyroid feedback in a patient with a sporadic activating thyrotropin (TSH) receptor mutation: implication that thyroid-secreted factors other than thyroid hormones contribute to serum TSH levels.
    Gelwane G, de Roux N, Chevenne D, Carel JC, Léger J.
    J Clin Endocrinol Metab; 2009 Aug 20; 94(8):2787-91. PubMed ID: 19454581
    [Abstract] [Full Text] [Related]

  • 18. Effect of dexamethasone on TSH secretion induced by TRH in human obesity.
    Coiro V, Volpi R, Capretti L, Speroni G, Pilla S, Cataldo S, Bianconcini M, Bazzani E, Chiodera P.
    J Investig Med; 2001 Jul 20; 49(4):330-4. PubMed ID: 11478409
    [Abstract] [Full Text] [Related]

  • 19. Low setting of feedback regulation of TSH secretion by thyroxine in pituitary dwarfism with TSH-releasing hormone deficiency.
    Sato T, Ishiguro K, Suzuki Y, Taketani T, Isumisawa A.
    J Clin Endocrinol Metab; 1976 Feb 20; 42(2):385-90. PubMed ID: 816807
    [Abstract] [Full Text] [Related]

  • 20. Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
    Kaplan MM, Taft JA, Reichlin S, Munsat TL.
    J Clin Endocrinol Metab; 1986 Oct 20; 63(4):808-14. PubMed ID: 3091628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.